Virtual 25th Annual European Hematology Association (EHA) Congress, June 11-21, 2020

EHA

17 czerwca 2020

Rok

2020

Cel

PIM/FLT3, daposertib (MEN1703 / SEL24), RVU120 (CDK8/CDK19)

Zasoby na tej stronie
Pobierz zasoby

plik pdf
“A First-in-human study of SEL120, a novel oral selective CDK8/19 inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome”
Pobierz
plik pdf
"Results of the dose escalation part of DIAMOND trial (CLI24-001): first in human study of SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor, in Patients with Acute Myeloid Leukemia"
Pobierz